Recombinant
RabMAb

Recombinant Anti-Ret antibody [EPR2871] (ab134100)

Rabbit recombinant monoclonal Ret antibody [EPR2871]. Validated in WB, IP, ELISA, IHC, ICC/IF and tested in Mouse, Rat, Human. Cited in 22 publication(s). Independently reviewed in 7 review(s).

Publishing research using ab134100? Please let us know so that we can cite the reference in this datasheet.

ab134100 has been referenced in 27 publications.

  • Schweppe RE  et al. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Mol Cancer Res 17:1036-1048 (2019). PubMed: 30733375
  • Nakasatomi M  et al. Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF. PLoS One 14:e0212991 (2019). PubMed: 30845150
  • Lopez-Delisle L  et al. Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis. Oncogene 37:1417-1429 (2018). PubMed: 29321660
  • Sun M  et al. Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm. Exp Ther Med 16:1216-1224 (2018). PubMed: 30116372
  • Pozo K  et al. Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer. Oncotarget 9:37662-37675 (2018). PubMed: 30701022
  • Nakaoku T  et al. A secondary RET mutation in the activation loop conferring resistance to vandetanib. Nat Commun 9:625 (2018). PubMed: 29434222
  • Tan L  et al. Expression and copy number gains of the RET gene in 631 early and mid stage non-small cell lung cancer cases. Thorac Cancer 9:445-451 (2018). IHC-P ; Human . PubMed: 29473341
  • Mabruk ZA  et al. The role of the ShcD and RET interaction in neuroblastoma survival and migration. Biochem Biophys Rep 13:99-108 (2018). PubMed: 29556564
  • Dhandapani R  et al. Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons. Nat Commun 9:1640 (2018). PubMed: 29691410
  • Kim JO  et al. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients. Surg Oncol 27:106-113 (2018). IHC-P ; Mouse, Human . PubMed: 29549897
  • Li Z  et al. HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients. Cell Rep 19:2515-2528 (2017). WB ; Human . PubMed: 28636940
  • Ye S  et al. TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma. Oncol Rep 37:2215-2226 (2017). IHC ; Human . PubMed: 28350084
  • Yang D  et al. Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease. Sci Rep 7:43222 (2017). WB . PubMed: 28256518
  • Vaishnavi A  et al. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Res 77:3551-3563 (2017). PubMed: 28428274
  • Ceolin L  et al. Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma. PLoS One 11:e0147840 (2016). IHC . PubMed: 26829565
  • Qiu X  et al. NEDL2 regulates enteric nervous system and kidney development in its Nedd8 ligase activity-dependent manner. Oncotarget 7:31440-53 (2016). PubMed: 27119228
  • Lee MS  et al. Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma. Oncotarget 7:36101-36114 (2016). PubMed: 27150058
  • Li Z  et al. miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-ß-catenin signaling pathway. Int J Oncol 49:1629-1637 (2016). PubMed: 27633255
  • Scapineli JO  et al. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer 15:625-33 (2016). PubMed: 26920351
  • Yu M  et al. HO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation. Oncol Lett 10:3137-3144 (2015). WB ; Human . PubMed: 26722301
  • Franz H  et al. The histone code reader SPIN1 controls RET signaling in liposarcoma. Oncotarget 6:4773-89 (2015). PubMed: 25749382
  • Cyr AR  et al. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene N/A:N/A (2014). PubMed: 24469049
  • Wiesner T  et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116 (2014). Human . PubMed: 24445538
  • Ali HM  et al. Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations. PLoS One 9:e95964 (2014). WB ; Mouse . PubMed: 24759995
  • Lee SE  et al. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma. Mod Pathol N/A:N/A (2014). PubMed: 25234288
  • Licciulli S  et al. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas. J Biol Chem 288:29105-14 (2013). WB ; Mouse . PubMed: 23960073
  • Fontana X  et al. c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J Cell Biol 198:127-41 (2012). Mouse . PubMed: 22753894

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up